Cholinesterase inhibitors and hospitalization for bradycardia: a population-based study - Wikidata - awgldk - TriplyDB

Cholinesterase inhibitors and hospitalization for bradycardia: a population-based study

Cholinesterase inhibitors and hospitalization for bradycardia: a population-based study

http://www.wikidata.org/entity/Q28476190

about

Withdrawal or continuation of cholinesterase inhibitors and/or memantine in patients with dementia Heart failure and Alzheimer's disease Persistence and adherence with dementia pharmacotherapy: relevance of patient, provider, and system factors Disease risk score as a confounder summary method: systematic review and recommendations A fixed-dose combination of memantine extended-release and donepezil in the treatment of moderate-to-severe Alzheimer's disease Comparative safety and effectiveness of cognitive enhancers for Alzheimer's dementia: protocol for a systematic review and individual patient data network meta-analysis Use of clarithromycin and adverse cardiovascular events among older patients receiving donepezil: a population-based, nested case-control study.Cardiovascular effects of drugs used to treat Alzheimer's disease.A Risk-Benefit Assessment of Dementia Medications: Systematic Review of the Evidence.The Use of Cholinesterase Inhibitors Across All Stages of Alzheimer's Disease.Upper gastrointestinal bleed associated with cholinesterase inhibitor use Safety and tolerability of donepezil 23 mg in moderate to severe Alzheimer's disease Current and emerging drug treatment options for Alzheimer's disease: a systematic review.Efficacy and tolerability of oxycodone in moderate-severe cancer-related pain: A meta-analysis of randomized controlled trials Long-term efficacy and toxicity of cholinesterase inhibitors in the treatment of Alzheimer disease.Potential therapeutic competition in community-living older adults in the U.S.: use of medications that may adversely affect a coexisting condition.Evaluation and management of the elderly patient presenting with cognitive complaints.The influence of cholinesterase inhibitor therapy for dementia on risk of cardiac pacemaker insertion: a retrospective, population-based, health administrative databases study in Ontario, Canada Efficacy of cognitive enhancers for Alzheimer's disease: protocol for a systematic review and network meta-analysis.Intermittent hypoxia training protects cerebrovascular function in Alzheimer's disease.Pharmacological recommendations for the symptomatic treatment of dementia: the Canadian Consensus Conference on the Diagnosis and Treatment of Dementia 2012.Adverse drug events as a cause of hospitalization in older adults.Pharmacotherapeutic strategies in the treatment of severe Alzheimer's disease.Ticagrelor and bradycardia: a nested case-control study.Adverse Drug Reactions Reported With Cholinesterase Inhibitors: An Analysis of 16 Years of Individual Case Safety Reports From VigiBase.Ensuring integrity in comparative effectiveness research: accentuate the negative.A metoprolol-terbinafine combination induced bradycardia.Cognitive enhancement therapy for a model of Down syndrome.Are we providing the best possible care for dementia patients?Withdrawal of Antidementia Drugs in Older People: Who, When and How?When should case-only designs be used for safety monitoring of medical products?Electrocardiogram Changes of Donepezil Administration in Elderly Patients with Ischemic Heart Disease.

P2860

Q24235324-89ABA97E-B2AC-4CCE-9162-2E28EBABC7DE Q26852526-F25236FA-D65D-443C-8DB8-2C0646BA4F03 Q26997299-3CCC7CAF-0843-4051-ACE0-51FE0F4D5A09 Q26999267-03A3639C-6C52-4A93-8EF6-71D9B1104D35 Q28076715-D9803298-5E36-4BFA-9D36-BEB1E74DDD7B Q28080099-3F704EF5-BDD2-4911-828E-C3057ABDB3A8 Q33161031-4FF41237-06B8-4B92-B267-4501362A0108 Q33164224-4F18A9E9-E9BC-42BC-9C8D-1FFA372CCD01 Q33165693-BBA945A3-8E2F-464A-BEB2-CA8E7EEF51D1 Q33165801-D3368EEA-2758-4564-8958-D169B9106267 Q33166305-86C5A0A7-FCE2-4285-9254-2557B6675EA3 Q33911859-BF8EBB48-CEBA-433A-8B86-3B706616B3AB Q34222721-C773F7AD-7283-4A06-A7B1-C63B890096BD Q34411964-105F058F-C968-4C86-A775-63CDA9B15774 Q35006354-4E371786-9CFB-4A66-A367-623B354B3D33 Q35107345-24DF023D-D6E6-4F52-A33D-4066E53185C4 Q35447239-ADB539A8-AA84-413F-ADC2-297CA1A40BB0 Q35568937-9069E94B-4CD3-4515-A461-FA65529A8150 Q36125353-90E5D193-D2BE-477D-B22D-D901071291A8 Q37106933-0D0F79C7-B8AB-4977-8D8C-AF84986BC95F Q37693772-46122C0A-5CAA-4093-9CBC-0A56136C7EA5 Q38085222-076E1DCE-31C6-4310-862D-6B4EAE51F735 Q38906350-52DCA83C-3E9C-415C-A9E1-EEC9742D47E1 Q40453126-6069E853-6819-415F-82F4-AB23BC1591C7 Q41436212-24CBAF68-878B-4E85-B45C-7D5A41BF98FA Q42551762-1AA6ADCB-2258-4509-9C1B-EC7BE479893B Q42705397-0ADA82C9-1B3C-462F-A226-9DD7D045F8A9 Q43109275-D373F1DB-5905-410B-9D13-096170519FA2 Q48079641-0C7EE019-A6B5-4DB4-A3F5-65D3418704DC Q48167336-918716C2-83BB-40C6-99DD-52298B177A30 Q53094489-09DC7D2C-05FA-4506-85EF-CEBC9286CFCD Q55231435-D3CC8791-084D-4C67-95C7-4D6F6ECE481D

P2860

Cholinesterase inhibitors and hospitalization for bradycardia: a population-based study

http://www.wikidata.org/entity/Q28476190

description

2009 nî lūn-bûn

@nan

2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Cholinesterase inhibitors and hospitalization for bradycardia: a population-based study

@ast

Cholinesterase inhibitors and hospitalization for bradycardia: a population-based study

@en

Cholinesterase inhibitors and hospitalization for bradycardia: a population-based study

@nl

type

label

Cholinesterase inhibitors and hospitalization for bradycardia: a population-based study

@ast

Cholinesterase inhibitors and hospitalization for bradycardia: a population-based study

@en

Cholinesterase inhibitors and hospitalization for bradycardia: a population-based study

@nl

prefLabel

Cholinesterase inhibitors and hospitalization for bradycardia: a population-based study

@ast

Cholinesterase inhibitors and hospitalization for bradycardia: a population-based study

@en

Cholinesterase inhibitors and hospitalization for bradycardia: a population-based study

@nl

P1433

Q28476190-FA4268A2-FE46-4018-9B41-7D7428999954

P1476

Q28476190-94F07E48-D10A-458D-A22B-F84B19E61942

P2093

Q28476190-465A7C1F-8AF3-41A6-94FE-B19F9810F194

Q28476190-767D2C08-DFF3-4D70-9520-70D292EEEC80

Q28476190-86AFE4F6-EF04-4218-8FC6-995C56F918B6

Q28476190-9074360B-2FAC-46A6-9A1F-FC2F790672CF

Q28476190-B2E907A8-060F-49F8-8B6E-A00B8433742E

Q28476190-DC2C40A3-C5F9-472E-A555-20D985D30F0A

P2860

Q28476190-0AE95E7B-13A2-4D3A-80EE-1B87A4A1F712

Q28476190-20C98EAB-19A1-4EAD-8A99-82652B4331AD

Q28476190-2B8F404F-DE9E-4B00-AFEC-3F85F419A6ED

Q28476190-396CA852-8986-4D7A-9809-64D68AC92951

Q28476190-3A42794A-3945-47F9-B220-B4D311047C5D

Q28476190-43978D83-F5DE-4158-BEC4-FF9B4DEB1B10

Q28476190-4E2598D3-1F07-4AD1-80F5-ECCA580883FA

Q28476190-51565D80-5B7A-4E55-A30C-086DCB972FF7

Q28476190-51ACE2AF-6926-45E9-9404-D1B476E22885

Q28476190-626D91F2-C841-4F96-9DDC-F16E3CE80D78

P304

Q28476190-81023271-3085-4C3E-B7A3-3A2D90EDE448

P31

Q28476190-DC7C68FC-5B4D-49BC-ABAF-6BEFA0C6FD2B

P3181

Q28476190-596BDD2B-14CA-4F24-AB0A-23F9E434DA5C

P356

Q28476190-49FD690A-146E-46AE-A104-8871183BF4B1

P407

Q28476190-DE71DEE2-093B-4BE3-98F4-ACA6C539FCE6

P433

Q28476190-D029ED38-E475-46E9-8581-5B0F3ED5FF3A

P478

Q28476190-05DC19F9-D2D2-4CE1-B151-298C977B0DB6

P577

Q28476190-F8464A2D-C932-4862-8ADB-8CAB33F26571

P5875

Q28476190-DF1AFFB7-0F0D-4522-9738-77E7E49439C7

P698

Q28476190-0B823AA2-4BF5-41FB-BA9A-15BC4A850DBE

P921

Q28476190-18477F21-1AC9-4520-BFFB-B32E1EAA9625

Q28476190-F49879BA-7DEC-47CA-8748-89366A463995

P932

Q28476190-5C69A32F-ADCD-44C9-A9E8-7F1DF67EC570

P3181

P356

JOURNAL.PMED.1000157

P1433

P1476

Cholinesterase inhibitors and hospitalization for bradycardia: a population-based study

@en

P2093

Andreas Laupacis

http://www.w3.org/2001/XMLSchema#string

David N Juurlink

http://www.w3.org/2001/XMLSchema#string

Laura Y Park-Wyllie

http://www.w3.org/2001/XMLSchema#string

Muhammad M Mamdani

http://www.w3.org/2001/XMLSchema#string

Ping Li

http://www.w3.org/2001/XMLSchema#string

Sudeep S Gill

http://www.w3.org/2001/XMLSchema#string

P2860

Effectiveness of Cholinesterase Inhibitors and Memantine for Treating Dementia: Evidence Review for a Clinical Practice Guideline

Use of statins and the subsequent development of deep vein thrombosis

Outpatient gatifloxacin therapy and dysglycemia in older adults

Significance of syncope in patients with Alzheimer's disease treated with cholinesterase inhibitors.

Cardiovascular effects and risk of syncope related to donepezil in patients with Alzheimer's disease.

Complete atrioventricular block and ventricular tachyarrhythmia associated with donepezil

Syncope and its consequences in patients with dementia receiving cholinesterase inhibitors: a population-based cohort study.

Should we use a case-crossover design?

Postmenopausal estrogen replacement therapy and increased rates of cholecystectomy and appendectomy

Cyclo-oxygenase-2 inhibitors versus non-selective non-steroidal anti-inflammatory drugs and congestive heart failure outcomes in elderly patients: a population-based cohort study.

P304

e1000157

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3167749

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PMED.1000157

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2009-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26853945

http://www.w3.org/2001/XMLSchema#string

P698

19787032

http://www.w3.org/2001/XMLSchema#string

P921

hospitalization

P932

2742897

http://www.w3.org/2001/XMLSchema#string